How Long Can You Be on Wegovy, and What Happens When You Stop?

NICE guidance for semaglutide (Wegovy) caps NHS use at a maximum of two years, within a specialist weight management service.
Private prescribing has no regulatory time limit, but clinical review before every repeat is essential, treatment should only continue while it is working and suitable.
NICE recommends reviewing whether to continue if a patient has lost less than 5% of their body weight after six months at the maintenance dose.
Weight regain after stopping is common; a prescriber can help you plan a structured exit or, where appropriate, a longer-term continuation strategy.

The honest answer to how long you can be on Wegovy is that it depends on two things: the clinical guidelines that apply to your route of access, and what your prescriber finds when they review your progress. Under NICE's recommendation for semaglutide, NHS patients can use it for a maximum of two years; private treatment has no fixed cut-off, but every continuation should be clinically justified. That said, the question of how long to be on Wegovy is rarely just about time — it is really about whether the medicine is still working for you, whether the risks remain acceptable, and what your long-term plan looks like. These are worth thinking through before you start, not after six months in. If you are already on treatment and wondering where you stand, that feeling of uncertainty is one our prescribers hear from people every week — and it is completely reasonable to want a clear answer.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Making the decision about how long to stay on Wegovy: the factors that actually matter

What the NICE guidance actually says about duration

NICE's appraisal of semaglutide for weight management, TA875, recommends it for use only within a specialist weight management service with multidisciplinary support, and only for a maximum of two years. That two-year ceiling exists specifically for the NHS route. It is not a biological rule or a pharmacological finding; it reflects how the cost-effectiveness case was made to NICE and the delivery model NHS England operates.

The guidance also sets a progress checkpoint: if someone has not lost at least 5% of their starting body weight after six months at the full maintenance dose, the clinical case for continuing is weak and stopping is the recommended course. That threshold is worth knowing before you begin, because it shapes how your progress will be assessed.

NICE also specifies that the 2.4mg maintenance dose sits within a titration pathway (treatment starts at a lower dose and increases gradually) and that ongoing management should involve lifestyle support alongside the medicine. You can read more about the full evidence base and access pathway on our Wegovy overview page.

Does the two-year limit apply to private treatment?

No, not as a hard rule. NICE's two-year recommendation governs NHS commissioning. Private prescribers operate under the same clinical and ethical obligations (they must follow the medicine's licensed indication and act in your best interests) but there is no regulation that stops a private prescription continuing beyond 24 months if it remains clinically appropriate.

What responsible private prescribing does require is ongoing review. At nume, every repeat order is assessed by a GPhC-registered Independent Prescriber before it is dispensed. A named clinician, not an automated system, reads your update each time. If your weight loss has plateaued, if a health change makes the medicine less suitable, or if the balance of benefit and risk has shifted, that prescriber will tell you. Continuation is not assumed; it is re-justified.

If you want a fuller picture of how long you can stay on Wegovy, including what ongoing review looks like in practice and the factors a prescriber weighs each time, we cover that in detail separately. Some people find two years is enough; others have clinical reasons to continue. The prescriber's job is to help you work out which applies to you.

What happens to weight when you stop Wegovy?

This is the part most people want to know and find hardest to hear. The STEP 1 trial, published in the New England Journal of Medicine, found that participants who stopped semaglutide regained a substantial proportion of the weight they had lost within about a year of stopping, even when they continued lifestyle changes. The appetite-suppressing effect of the medicine is pharmacological: when the drug clears your system, the signals that had been quietened return.

That is not a reason to avoid the medicine. For many people the period on treatment creates real metabolic and lifestyle change that has lasting value. But it does mean that stopping should be planned rather than abrupt, and that the transition off treatment deserves as much clinical attention as the start. If you are curious about how Wegovy compares over time with other options, our page on how long you can be on semaglutide covers the broader picture across different semaglutide formulations.

Your prescriber can help you map out a sensible stopping strategy, whether that means a gradual taper, intensifying lifestyle support in the months before stopping, or (in some clinical situations) switching to a different approach. There is no single right answer, which is why a conversation with a clinician beats a forum thread every time.

Deciding whether to continue, pause or stop: the practical question

Most people asking how long they can take Wegovy are really asking: is it still worth it? That question has three honest parts. First, is it still working? A prescriber will look at your current weight, your progress curve and whether you are still in active loss or have stabilised. Second, is it still safe? Health changes, new medicines or a pregnancy plan can all shift the picture. Third, what comes after? If treatment stops, what support is in place?

Thinking about cost is legitimate too. Private Wegovy is a meaningful monthly outlay, and understanding what that money includes (clinical oversight, prescription, delivery, aftercare access) matters when you are planning months or years ahead. Our treatment options page sets out what is included in one transparent price, with no subscription or auto-renewal.

If you are still in the earlier stages and wondering how long you can be on Wegovy for weight loss, including what the evidence says about results over time and when returns tend to plateau, we cover that separately in full. And if you are weighing up whether to start at all, our weight loss overview can help you see the full range of clinically supervised options available through nume.

The decision about duration is yours, made with clinical guidance. Speak to our prescribers if you want a clear assessment of where you are and where you go next.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions